Jul 25, 09:10
Jul 25, 09:08
84% of moneycontrol users recommend buying Biocon.
What's your call on Biocon today?
Read 99 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2745.85||1.30||2939.80||2140.35||46,771.45|
|Mar' 14||Sep' 13||Jun' 13||Mar' 13|
Jindal PolyFilms Recommended on May 27th 2014
Recommended price 177.00 | Peak from reco 278.40 57.29%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Biocon is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 9,601.00 crore.The company has reported a consolidated sales of Rs 722.59 crore and a Net Profit of Rs 118.91 crore for the quarter ended Mar 2014.
The company management includes Kiran Mazumdar Shaw - Chairman & Managing Director, John Shaw - Vice Chairman, Charles L Cooney - Director, Mary Harney - Director, Ravi Mazumdar - Director, Ravi Mazumdar - Director, Russell Walls - Director, Suresh N Talwar - Director, Daniel M Bradbury - Additional Director, Bala S Manian - Director, Arun Suresh Chandavarkar - Joint Managing Director & CEO.
It is listed on the BSE with a BSE Code of 532523 and the NSE with an NSE Code of BIOCON.
Its Registered office is at 20th K M, Hosur Road, Electronic City P O, Bangalore,Karnataka - 560100.
Their Registrars are Karvy Computershare Private Ltd.